Global Opioid Use Disorder Market Overview:
Global Opioid Use Disorder Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Opioid Use Disorder Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Opioid Use Disorder involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Opioid Use Disorder Market:
The Opioid Use Disorder Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Opioid Use Disorder Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Opioid Use Disorder Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Opioid Use Disorder market has been segmented into:
Buprenorphine
Naltrexone
Methadone
By Application, Opioid Use Disorder market has been segmented into:
Intravenous
Oral
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Opioid Use Disorder market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Opioid Use Disorder market.
Top Key Players Covered in Opioid Use Disorder market are:
Alkermes
Inc.
Indivior PLC
BioDelivery Sciences International
Inc.
Orexo US
Inc.
Titan Pharmaceuticals
Inc.
Omeros Corporation
Camurus
Hikma PharmaceuticalsPLC
AstraZeneca plc
Viatris Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Opioid Use Disorder Market Type
4.1 Opioid Use Disorder Market Snapshot and Growth Engine
4.2 Opioid Use Disorder Market Overview
4.3 Buprenorphine
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Buprenorphine: Geographic Segmentation Analysis
4.4 Naltrexone
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Naltrexone: Geographic Segmentation Analysis
4.5 Methadone
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Methadone: Geographic Segmentation Analysis
Chapter 5: Opioid Use Disorder Market Application
5.1 Opioid Use Disorder Market Snapshot and Growth Engine
5.2 Opioid Use Disorder Market Overview
5.3 Intravenous
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Intravenous: Geographic Segmentation Analysis
5.4 Oral
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Oral: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Opioid Use Disorder Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ALKERMES
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.
6.4 INDIVIOR PLC
6.5 BIODELIVERY SCIENCES INTERNATIONAL
6.6 INC.
6.7 OREXO US
6.8 INC.
6.9 TITAN PHARMACEUTICALS
6.10 INC.
6.11 OMEROS CORPORATION
6.12 CAMURUS
6.13 HIKMA PHARMACEUTICALSPLC
6.14 ASTRAZENECA PLC
6.15 VIATRIS INC.
Chapter 7: Global Opioid Use Disorder Market By Region
7.1 Overview
7.2. North America Opioid Use Disorder Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Buprenorphine
7.2.2.2 Naltrexone
7.2.2.3 Methadone
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Intravenous
7.2.3.2 Oral
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Opioid Use Disorder Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Buprenorphine
7.3.2.2 Naltrexone
7.3.2.3 Methadone
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Intravenous
7.3.3.2 Oral
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Opioid Use Disorder Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Buprenorphine
7.4.2.2 Naltrexone
7.4.2.3 Methadone
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Intravenous
7.4.3.2 Oral
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Opioid Use Disorder Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Buprenorphine
7.5.2.2 Naltrexone
7.5.2.3 Methadone
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Intravenous
7.5.3.2 Oral
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Opioid Use Disorder Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Buprenorphine
7.6.2.2 Naltrexone
7.6.2.3 Methadone
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Intravenous
7.6.3.2 Oral
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Opioid Use Disorder Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Buprenorphine
7.7.2.2 Naltrexone
7.7.2.3 Methadone
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Intravenous
7.7.3.2 Oral
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Opioid Use Disorder Scope:
|
Report Data
|
Opioid Use Disorder Market
|
|
Opioid Use Disorder Market Size in 2025
|
USD XX million
|
|
Opioid Use Disorder CAGR 2025 - 2032
|
XX%
|
|
Opioid Use Disorder Base Year
|
2024
|
|
Opioid Use Disorder Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Alkermes, Inc., Indivior PLC, BioDelivery Sciences International, Inc., Orexo US, Inc., Titan Pharmaceuticals, Inc., Omeros Corporation, Camurus, Hikma PharmaceuticalsPLC, AstraZeneca plc, Viatris Inc..
|
|
Key Segments
|
By Type
Buprenorphine
Naltrexone
Methadone
By Applications
Intravenous
Oral
|
